The India Cardiovascular Devices Market Report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Application (Coronary Artery Disease, Arrhythmia & Conduction Disorders, Heart Failure & Cardiomyopathy, and More), End User (Hospitals & Cardiac Centres, Ambulatory Surgical Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).

The global cardiovascular devices market size was worth over USD 69.06 billion in 2025 and is poised to grow at a CAGR of around 7.8%, reaching USD 146.36 billion revenue by 2035, driven by growing minimal invasive medical procedures.

The global cardiovascular devices market size reached USD 62.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 101.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033. The introduction of interventional cardiology procedures, coupled with favorable reimbursement policies, are stimulating the market growth

IMARC Group provides an analysis of the key trends in each segment of the market, along with the cardiovascular devices market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on the device type, application, and end user.

Global Cardiovascular Devices market size was $7.98 billion in 2023 and is slated to hit $14.36 billion by the end of 2032 with a CAGR of 6.74%.

The China Cardiovascular Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Application (Coronary Artery Disease, Arrhythmia & Conduction Disorders, Heart Failure & Cardiomyopathy, and More), End-User (Hospitals & Cardiac Centres, Ambulatory Surgical Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).

Cardiovascular Device Market size to hit USD 128.23 billion by 2034, market analysis reveals breakthrough stents, pacemakers & AI-powered monitoring solutions

The United States Cardiovascular Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices [ECG Systems, Remote Cardiac Monitor, and More], Therapeutic & Surgical Devices [Coronary Stents, Catheters, Cardiac Rhythm Management, Heart Valves, Ventricular Assist Devices, and More]), Indication (Coronary Artery Disease, Arrhythmia, and More). The Market Forecasts are Provided in Terms of Value (USD).

Find detailed analysis in Market Research Intellect's Cardiovascular Devices Market Report, estimated at USD 50.3 billion in 2024 and forecasted to climb to USD 75.2 billion by 2033, reflecting a CAGR of 5.5%.Stay informed about adoption trends, evolving technologies, and key market participants.

Snapshot img

Cardiovascular Medical Devices Market Size 2025-2029

The cardiovascular medical devices market size is forecast to increase by USD 21.71 billion at a CAGR of 7.6% between 2024 and 2029.

The market is driven by the escalating incidence of cardiovascular diseases and the expansion of insurance providers' coverage for related treatments. Market players are responding with innovative business strategies, including product development and strategic collaborations, to capitalize on these opportunities. However, the high cost of cardiovascular procedures poses a significant challenge for both patients and providers, potentially limiting market growth. Artificial intelligence and wireless technologies, such as Al-based electrocardiograms, implantable loop recorders, and event monitors, are also gaining popularity for their ability to improve diagnostic accuracy and patient care.
Effective cost management and continuous innovation will be essential for market success. As the population ages and cardiovascular diseases become increasingly prevalent, companies must navigate this financial obstacle while maintaining quality and affordability to meet patient needs and remain competitive. Companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis.

What will be the Size of the Cardiovascular Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The Cardiovascular Devices Market encompasses diagnostic monitoring devices, surgical devices, and cardiology devices used to prevent and manage heart disorders, including cardiomyopathy, heart failure, stroke, and heart-related mortality. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, making this market crucial for addressing healthcare resources and improving patient outcomes. Emerging nations are increasingly investing in advanced cardiovascular devices, such as AI-based ECG technology and minimally invasive procedures, to reduce fatal conditions like heart failure and stroke. The market is witnessing significant trends, including the integration of artificial intelligence in diagnostics and the development of more sophisticated surgical devices, such as coronary artery stents.

Cardiovascular Diseases, including heart disorders and heart-related mortality, are major health concerns, and the demand for diagnostic monitoring devices, such as Holter monitors, is on the rise. The market's growth is driven by the need for early detection and effective management of cardiovascular conditions, as well as advancements in technology, such as minimally invasive procedures and AI-based electrocardiogram technology. The Cardiovascular Devices Market is expected to continue growing, as healthcare systems in both developed and emerging nations seek to improve patient care and reduce the burden of cardiovascular diseases. With advancements in technology and a growing focus on preventative care, the market is poised for continued growth and innovation.

How is this Cardiovascular Medical Devices Industry segmented?

The cardiovascular medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Diagnostic systems
  Surgical devices


Disease Type

  Coronary artery disease
  Arrhythmia
  Heart failure
  Structural heart disease
  Others


End-user

  Hospitals
  ASCs
  Specialty clinics
  Home healthcare settings
  Rehabilitation centers


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The Diagnostic systems segment is estimated to witness significant growth during the forecast period. The market encompasses a vast array of technologies and devices designed to diagnose, monitor, and treat heart disorders and diseases. This market includes innovative solutions such as AI-based electrocardiogram (ECG) technology, implantable loop recorders, cardiac CT scans, and minimally invasive procedures for detecting clogged arteries and assessing heart function. Valves, pacemakers, stents, Holter monitors, and electrosurgical procedures are among the essential cardiovascular devices used for treating various heart conditions. The World Health Organization reports that cardiovascular diseases (CVDs) are the leading cause of heart-related mortality worldwide. Fatal conditions like atrial fibrillation, stroke, and heart attacks n

The Chilean cardiovascular devices market, valued at an estimated $100 million in 2025, is projected to experience steady growth, driven by factors such as increasing prevalence of cardiovascular diseases, a rising geriatric population, and improving healthcare infrastructure. The market's Compound Annual Growth Rate (CAGR) of 2.40% from 2025 to 2033 indicates a consistent, albeit moderate, expansion. This growth is fueled by rising adoption of minimally invasive procedures, technological advancements in device design leading to improved outcomes, and increased government initiatives focused on improving cardiovascular health. The market segmentation reveals strong demand for both diagnostic and monitoring devices (ECG, remote cardiac monitoring systems) and therapeutic and surgical devices (cardiac rhythm management devices, stents, heart valves). Major players like Boston Scientific, Medtronic, and Siemens Healthineers are actively engaged in the Chilean market, contributing to its development through product innovation and distribution networks. However, factors such as high device costs, limited healthcare access in certain regions, and the presence of generic alternatives could pose challenges to sustained market expansion. The market's performance is expected to be influenced by several factors. Government healthcare policies, including investment in public health programs and reimbursement schemes for advanced cardiovascular devices, will play a crucial role. The adoption of telehealth technologies for remote patient monitoring is anticipated to boost the market segment for remote cardiac monitoring devices. Furthermore, the expanding private healthcare sector and increasing medical tourism could contribute positively to market growth. A potential constraint could be the economic conditions in Chile and its impact on healthcare spending. Nonetheless, the overall outlook remains positive, suggesting a stable and gradually expanding cardiovascular devices market in Chile throughout the forecast period (2025-2033). Key drivers for this market are: , Increasing Burden of Cardiovascular Diseases; Increased Preference of Minimally Invasive Procedures. Potential restraints include: , Increasing Burden of Cardiovascular Diseases; Increased Preference of Minimally Invasive Procedures. Notable trends are: Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period.

Cardiovascular Devices Market size was valued at USD 63.49 Billion in 2024 and is projected to reach USD 104.08 Billion by 2032, growing at a CAGR of 7.03% from 2026 to 2032.Rising Prevalence of Cardiovascular Diseases (CVDs): The most fundamental driver for the Cardiovascular Devices Market, creating an ever expanding patient pool requiring intervention and management. The increasing global incidence of complex conditions such as coronary artery disease (CAD), congestive heart failure (CHF), structural heart defects, and various arrhythmias necessitates a continuous supply of sophisticated diagnostic, monitoring, and therapeutic devices.

According to Cognitive Market Research, the Cardiovascular Devices Market Size was USD XX Billion in 2024 and is set to achieve a market size of USD XX Billion by the end of 2033 growing at a CAGR of XX% from 2025 to 2033.

North America held largest share of XX% in the year 2024 
Europe held share of XX% in the year 2024 
Asia-Pacific held significant share of XX% in the year 2024 
South America held significant share of XX% in the year 2024
Middle East and Africa held significant share of XX% in the year 2024 

Market Dynamics of the Cardiovascular Devices Market

Key Drivers for the Cardiovascular Devices Market

Rising in cardiovascular diseases prevalence fuels the cardiovascular devices market

The cardiovascular disorders are the group of medical condition where it affects heart and blood vessels, encompassing various diseases and disorder that affects on the circulatory system. The cardiac devices help to maintain the regular heart function and blood flow in patients with weak improper function of heart. The global cardiac device market shows significant growth, largely driven by increase in prevalence of heart disease. The cardiovascular disease treatment is costly in terms of healthcare services. Now the conditions like coronary artery disease and heart failure are becoming increasingly prevalent, so there is increase in demand of coronary stents and crucial devices which are used to treat the cardiovascular diseases. Also, the global population increases and continues to age the incidence of chronic heart condition is expected to rise. This demographic condition is shift further and results in growing need of cardiovascular devices that can treat the wide range of heart diseases.

For instance, according to centers for disease control and prevention (CDC) in the United States heart diseases is the major cause of death for both men and women and people of most racial and ethnic groups. They said that one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That is equivalent to 1 in every 5 deaths

(Source -https://www.cdc.gov/heart-disease/index.html)

Thus, due to the rising patients in cardiovascular disease segment and the advancement in technology boosts the cardiovascular devices market. Rising awareness of health also helps to drive this market.

The rise in healthcare expenditure drives the Cardiovascular Devices Market

Globally the health awareness is increasing vastly countries monitor their health of the population related to cardiac health preferably. They also focus on the expansion of healthcare expenditure where the people also now get aware about their health. The advancement in technology of medical devices increases the patient convenience and now they can get treatment and monitor their health more effectively. Each country now spends on their healthcare expenditure to provide healthcare service to all needy people who cannot afford the costly devices. For instance, U.S. health expenditure grew by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This rate of growth is similar to pre-pandemic levels (4.1% in 2019). While government expenditure to contain the pandemic resulted in significant growth in NHE, these expenditures fell sharply in 2021 while use of medical goods and services recovered. By 2022, overall trends in health expenditure more closely approximated that of the pre-pandemic era.

(Source - https://www.ama-assn.org/about/research/trends-health-care-spending)

The market for cardiovascular devices is expected to grow as a result of rising healthcare costs. The total amount spent on healthcare-related services, goods, and activities over a given time period usually at the individual, community, national, or international level is referred to as healthcare expenditures. Adoption of cutting-edge cardiovascular technologies and devices is made possible by increased healthcare spending, which improves patient outcomes and care. For Instance, in Europe the spending on cardiovascular disease is greater than the spending done in Germany. CVD is estimated to cost the EU €282 billion annually, with health and long-term care accounting for €155 billion (55%), equaling 11% of EU-health expenditure. Productivity losses accounted for 17% (€48 billion), whereas informal care costs were €79 billion (28%). CVD ...

In 2024, Market Research Intellect valued the Cardiovascular Devices Market Report at 48.5 billion USD, with expectations to reach 73.2 billion USD by 2033 at a CAGR of 6.1%.Understand drivers of market demand, strategic innovations, and the role of top competitors.

This statistic shows the value of the cardiovascular devices market in Canada in 2007 and 2014, with a forecast for 2021, by category. In 2014, the total value of the cardiovascular devices market in Canada was around *** million U.S. dollars, with cardiac rhythm management devices accounting for the largest share of this total with over *** million dollars.

The global cardiovascular devices market is booming, projected to reach [estimated 2033 market size] by 2033, driven by an aging population, rising CVD prevalence, and technological advancements. Learn about market trends, key players (Abbott, Medtronic, Boston Scientific), and growth opportunities in this comprehensive analysis. Recent developments include: October 2022: Medtronic plc received United States FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods, such as cardiomyopathy., October 2022 : Biosense Webster, Inc., part of Johnson & Johnson MedTech launched the HELIOSTAR Balloon Ablation Catheter in Europe. The HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.. Key drivers for this market are: Rapid Technological Advancements, Increasing Burden of Cardiovascular Diseases; Increased Preference for Minimally Invasive Procedures. Potential restraints include: Rapid Technological Advancements, Increasing Burden of Cardiovascular Diseases; Increased Preference for Minimally Invasive Procedures. Notable trends are: The Electrocardiogram (ECG) Under Diagnostic and Monitoring Devices Segment is Expected to Hold a Significant Share in the Market.

The U.S. cardiovascular devices market was valued at USD 22.35 billion in 2024 and is expected to grow to USD 38.49 billion by 2034, registering a CAGR of 5.6% during the forecast period from 2025 to 2034.

The size of the United States Cardiovascular Devices Market was valued at USD 120 Million in 2023 and is projected to reach USD 150 Million by 2032, with an expected CAGR of 7.80% during the forecast period. Recent developments include: In November 2021, the company Royal Philips announced the acquisition of Cardiologs to expand its cardiac diagnostics and monitoring portfolio, In March 2021, the United States Food and Drug Administration approved a non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract (RVOT), In June 1, 2020, Boston Scientific Unites States launched the DIRECTSENSE Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures.. Key drivers for this market are: Rapid Technological Advancements, Increasing Burden of Cardiovascular Diseases; Increased Preference of Minimally Invasive Procedures. Potential restraints include: Stringent Regulatory Policies, High Cost of Instruments and Procedures. Notable trends are: Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period.

The Sweden Cardiovascular Devices Market, valued at approximately $330 million in 2025, is projected to experience steady growth, exhibiting a compound annual growth rate (CAGR) of 4.20% from 2025 to 2033. This growth is driven by several key factors. An aging population in Sweden, coupled with rising prevalence of cardiovascular diseases like coronary artery disease, heart failure, and arrhythmias, significantly fuels the demand for advanced diagnostic and therapeutic devices. Technological advancements in minimally invasive procedures, remote patient monitoring, and implantable devices further contribute to market expansion. Increased healthcare expenditure and improved healthcare infrastructure within the country also play a supportive role. The market is segmented by device type, encompassing diagnostic and monitoring devices (ECG, remote cardiac monitoring, others) and therapeutic and surgical devices (cardiac assist devices, cardiac rhythm management devices, catheters, stents, others). Leading players like Abbott Laboratories, Medtronic, and Boston Scientific are actively engaged in developing innovative products and expanding their market presence, fostering competition and driving innovation. However, certain restraints may influence the market's trajectory. The high cost associated with advanced cardiovascular devices can limit accessibility for some patients, particularly those without comprehensive insurance coverage. Stringent regulatory approvals and reimbursement processes can also pose challenges for market entrants and existing players. Furthermore, the market might experience fluctuations based on government healthcare policies and funding allocations. Despite these restraints, the long-term outlook for the Swedish cardiovascular devices market remains positive, primarily driven by the persistent need for effective cardiovascular disease management and the continuous development of advanced technologies. The market is expected to witness significant growth throughout the forecast period, offering lucrative opportunities for both established companies and emerging players. Recent developments include: July 2023: Neko Health, a Swedish startup, received a funding of EUR 60 million (USD 65.8 million) in Series A financing. The Stockholm-based startup's medical scanning technology aims to collect extensive health data to aid doctors in catching diseases early, including cardiovascular diseases., January 2022: The first successful pig heart transplant into a human patient was largely made possible by an organ preservation device from the Swedish company XVIVO. When surgeons at the University of Maryland School of Medicine successfully implanted a donor heart (pig heart) into a 57-year-old patient, the heart perfusion device of the XVIVO preserved the pig heart used in the surgery.. Key drivers for this market are: Rapid Technological Advancements, Increasing Burden of Cardiovascular Diseases; Increased Preference of Minimally Invasive Procedures. Potential restraints include: Rapid Technological Advancements, Increasing Burden of Cardiovascular Diseases; Increased Preference of Minimally Invasive Procedures. Notable trends are: Stents is Expected to Witness Growth Over the Forecast Period.

[231+ Pages Report] The global cardiovascular devices market size is expected to grow from USD 5.8 billion in 2022 to USD 20.34 billion by 2030, at a CAGR of 13% from 2023-2030

The global cardiovascular devices market was valued at USD 56.50 Billion in 2024, driven by increasing incidence of cardiovascular conditions across the globe. The market is expected to grow at a CAGR of 6.36% during the forecast period of 2025-2034, with the values likely to reach USD 104.67 Billion by 2034.